Supernova Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Subscribe To Our Newsletter & Stay Updated